242 related articles for article (PubMed ID: 16457596)
1. Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma.
Comunale MA; Lowman M; Long RE; Krakover J; Philip R; Seeholzer S; Evans AA; Hann HW; Block TM; Mehta AS
J Proteome Res; 2006 Feb; 5(2):308-15. PubMed ID: 16457596
[TBL] [Abstract][Full Text] [Related]
2. Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma.
Liao J; Zhang R; Qian H; Cao L; Zhang Y; Xu W; Li J; Wu M; Yin Z
Biochem Biophys Res Commun; 2012 Apr; 420(2):308-14. PubMed ID: 22425980
[TBL] [Abstract][Full Text] [Related]
3. Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans.
Block TM; Comunale MA; Lowman M; Steel LF; Romano PR; Fimmel C; Tennant BC; London WT; Evans AA; Blumberg BS; Dwek RA; Mattu TS; Mehta AS
Proc Natl Acad Sci U S A; 2005 Jan; 102(3):779-84. PubMed ID: 15642945
[TBL] [Abstract][Full Text] [Related]
4. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
[TBL] [Abstract][Full Text] [Related]
5. Glycoproteomic analysis by two-dimensional electrophoresis.
Comunale MA; Mehta A
Methods Mol Biol; 2009; 520():59-74. PubMed ID: 19381947
[TBL] [Abstract][Full Text] [Related]
6. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
[TBL] [Abstract][Full Text] [Related]
7. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
8. Lower serum viral loads in young patients with hepatitis-B-virus-related hepatocellular carcinoma.
Tsai FC; Liu CJ; Chen CL; Chen PJ; Lai MY; Kao JH; Chen DS
J Viral Hepat; 2007 Mar; 14(3):153-60. PubMed ID: 17305880
[TBL] [Abstract][Full Text] [Related]
9. Fucosylated glycoproteins as markers of liver disease.
Mehta A; Block TM
Dis Markers; 2008; 25(4-5):259-65. PubMed ID: 19126969
[TBL] [Abstract][Full Text] [Related]
10. Proteomics in the diagnosis of hepatocellular carcinoma: focus on high risk hepatitis B and C patients.
El-Aneed A; Banoub J
Anticancer Res; 2006; 26(5A):3293-300. PubMed ID: 17094443
[TBL] [Abstract][Full Text] [Related]
11. Protein expression and fucosylated glycans of the serum haptoglobin-{beta} subunit in hepatitis B virus-based liver diseases.
Shu H; Zhang S; Kang X; Li S; Qin X; Sun C; Lu H; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):528-34. PubMed ID: 21606158
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags.
Yoon SY; Kim JM; Oh JH; Jeon YJ; Lee DS; Kim JH; Choi JY; Ahn BM; Kim S; Yoo HS; Kim YS; Kim NS
Int J Oncol; 2006 Aug; 29(2):315-27. PubMed ID: 16820872
[TBL] [Abstract][Full Text] [Related]
13. Different expression of apoptotic proteins between HBV-infected and non-HBV-infected hepatocellular carcinoma.
Chang CS; Huang SM; Lin HH; Wu CC; Wang CJ
Hepatogastroenterology; 2007; 54(79):2061-8. PubMed ID: 18251160
[TBL] [Abstract][Full Text] [Related]
14. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
[TBL] [Abstract][Full Text] [Related]
15. Identification and analysis of altered alpha1,6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis.
Dai Z; Liu YK; Cui JF; Shen HL; Chen J; Sun RX; Zhang Y; Zhou XW; Yang PY; Tang ZY
Proteomics; 2006 Nov; 6(21):5857-67. PubMed ID: 17068759
[TBL] [Abstract][Full Text] [Related]
16. Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma.
He QY; Zhu R; Lei T; Ng MY; Luk JM; Sham P; Lau GK; Chiu JF
J Cell Biochem; 2008 Feb; 103(3):740-52. PubMed ID: 17557278
[TBL] [Abstract][Full Text] [Related]
17. Abnormal expression of HSP gp96 associated with HBV replication in human hepatocellular carcinoma.
Yao DF; Wu XH; Su XQ; Yao M; Wu W; Qiu LW; Zou L; Meng XY
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):381-6. PubMed ID: 16911935
[TBL] [Abstract][Full Text] [Related]
18. N-glycan profiles as tools in diagnosis of hepatocellular carcinoma and prediction of healthy human ageing.
Vanhooren V; Liu XE; Franceschi C; Gao CF; Libert C; Contreras R; Chen C
Mech Ageing Dev; 2009; 130(1-2):92-7. PubMed ID: 19070631
[TBL] [Abstract][Full Text] [Related]
19. Glycomic analyses of glycoproteins in bile and serum during rat hepatocarcinogenesis.
Nakagawa T; Takeishi S; Kameyama A; Yagi H; Yoshioka T; Moriwaki K; Masuda T; Matsumoto H; Kato K; Narimatsu H; Taniguchi N; Miyoshi E
J Proteome Res; 2010 Oct; 9(10):4888-96. PubMed ID: 20731380
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus DNA in patients with hepatitis B-related liver cirrhosis with or without hepatocellular carcinomas: a matched case-control study.
Xu J; Lin Y; Wang YP; Chen YX; Shi B; Lu J; Xie WF
J Dig Dis; 2009 May; 10(2):138-44. PubMed ID: 19426397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
